Phosphatidylserine Receptors Enhance SARS-CoV-2 Infection: AXL as a Therapeutic Target for COVID-19

Dana Bohan(University of Iowa), Wendy Maury(University of Iowa)

bioRxiv (Cold Spring Harbor Laboratory)

June 15, 2021

10.1101/2021.06.15.448419

Cited by 16

Related Papers

Phosphatidylserine receptors enhance SARS-CoV-2 infection

|PLoS Pathogens|2021|131